TriaGen Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Hold
705
0.06% 166
2026
Q1
$248K Hold
705
0.07% 161
2025
Q4
$231K Buy
+705
New +$224K 0.06% 162
2025
Q3
Sell
-719
Closed -$201K 184
2025
Q2
$201K Buy
719
+29
+4% +$8.22K 0.06% 167
2025
Q1
$215K Buy
+690
New +$204K 0.08% 154
2024
Q4
Sell
-690
Closed -$222K 170
2024
Q3
$222K Sell
690
-7
-1% -$2.29K 0.07% 162
2024
Q2
$218K Buy
+697
New +$205K 0.08% 152
2024
Q1
Sell
-697
Closed -$201K 164
2023
Q4
$201K Sell
697
-100
-13% -$27.2K 0.1% 152
2023
Q3
$214K Buy
+797
New +$199K 0.11% 143

Other funds holding AMGN

TriaGen Wealth Management's AMGN Position: Q2 2026 in Review

TriaGen Wealth Management held its Amgen (AMGN) position steady in Q2 2026 at 705 shares worth $255K. The position accounts for 0.06% of the portfolio, ranked #166.

TriaGen Wealth Management first reported a position in AMGN in Q3 2023 and has held it in 9 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • TriaGen Wealth Management held 705 shares of Amgen worth $255K as of Q2 2026.
  • TriaGen Wealth Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.06% of TriaGen Wealth Management's portfolio in Q2 2026, its #166 holding.
  • TriaGen Wealth Management first reported a position in Amgen in Q3 2023 and has held it in 9 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.